Biochemistry Enzyme Inducers/Inhibitors
- Crack Medicine
- 1 day ago
- 5 min read
TL;DR
Revision: Biochemistry Enzyme Inducers/Inhibitors is a small but consistently tested topic in MRCP Part 1 because it links pharmacology, biochemistry and clinical medicine. Candidates should recognise the common cytochrome P450 enzyme inducers and inhibitors, predict drug interactions, and understand their clinical consequences. This guide covers the five most examined themes, high-yield facts, common examination traps, a practice MCQ and a practical revision checklist.
Why this matters
Drug metabolism is a favourite integration topic in MRCP Part 1. Questions rarely ask candidates to memorise isolated drug lists. Instead, they present a clinical scenario involving altered drug efficacy, toxicity or unexpected laboratory findings caused by enzyme induction or inhibition.
Understanding hepatic enzyme activity allows you to predict interactions rather than memorise every combination. This approach is particularly valuable when revising alongside the MRCP Part 1 overview and practising application questions through the Free MRCP MCQs.
The majority of examination questions focus on the hepatic cytochrome P450 (CYP450) enzyme system, although Phase II metabolism and genetic variation occasionally appear.
Core sections
What are enzyme inducers and inhibitors?
Drug metabolism occurs predominantly in the liver through the cytochrome P450 enzyme family.
Enzyme induction increases enzyme synthesis, accelerating metabolism.
Enzyme inhibition reduces enzyme activity, slowing metabolism.
The clinical consequences depend on whether the affected drug is active or a prodrug.
Enzyme induction
Faster metabolism
Reduced plasma concentration of active drugs
Reduced therapeutic efficacy
Increased activation of certain prodrugs
Enzyme inhibition
Slower metabolism
Higher plasma concentration
Increased toxicity
Reduced activation of some prodrugs
Understanding this principle solves most MRCP questions.
The five most tested subtopics
1. CYP450 enzyme induction
This is probably the highest-yield area.
Common enzyme inducers include:
Rifampicin
Carbamazepine
Phenytoin
Phenobarbital
Primidone
St John's Wort
Chronic alcohol use
Griseofulvin
These drugs increase hepatic enzyme production over several days.
Clinical consequences include:
Reduced warfarin effect
Reduced oral contraceptive efficacy
Lower ciclosporin concentrations
Reduced corticosteroid levels
Increased metabolism of many antiepileptics
2. CYP450 enzyme inhibition
Enzyme inhibitors act more rapidly because they suppress existing enzyme activity.
Important inhibitors include:
Macrolides (especially erythromycin and clarithromycin)
Azole antifungals
Cimetidine
Amiodarone
Sodium valproate
Ciprofloxacin
Protease inhibitors
Grapefruit juice
Clinical effects include:
Warfarin toxicity
Increased statin concentrations
Digoxin interactions (although largely via P-glycoprotein)
Increased theophylline toxicity
Higher ciclosporin concentrations
3. Drug interactions involving warfarin
Warfarin remains one of the most frequently examined drugs in MRCP Part 1.
Remember:
Inducers decrease INR
Examples:
Rifampicin
Carbamazepine
Phenytoin
Inhibitors increase INR
Examples:
Metronidazole
Macrolides
Azoles
Amiodarone
Questions often present unexpected bleeding after prescribing an antibiotic.
4. Oral contraceptive interactions
Candidates frequently forget this classic association.
Strong enzyme inducers reduce circulating oestrogen concentrations.
Important examples:
Rifampicin
Carbamazepine
Phenytoin
Phenobarbital
Patients require additional contraceptive advice.
5. Prodrug activation
A favourite examination trap.
Not all increased metabolism is harmful.
Some drugs require metabolic activation.
Examples include:
Clopidogrel
Codeine
Tamoxifen
Enzyme inhibition may reduce efficacy rather than increase toxicity.
High-yield comparison table
Feature | Enzyme Inducers | Enzyme Inhibitors |
Mechanism | Increase enzyme synthesis | Reduce enzyme activity |
Onset | Slow (days) | Rapid (hours to days) |
Drug concentration | Falls | Rises |
Toxicity | Usually decreases | Usually increases |
Treatment failure | Common | Less common |
Common examples | Rifampicin, Carbamazepine, Phenytoin | Macrolides, Azoles, Cimetidine |
Warfarin effect | INR decreases | INR increases |
Oral contraceptive effect | Reduced | Usually unchanged |
Twelve high-yield facts for rapid revision
Rifampicin is one of the strongest CYP450 inducers.
Carbamazepine induces its own metabolism (auto-induction).
Macrolides commonly inhibit CYP3A4.
Azole antifungals are important enzyme inhibitors.
Enzyme induction develops gradually.
Enzyme inhibition occurs relatively quickly.
Warfarin toxicity is commonly tested.
Oral contraceptive failure is a classic consequence of induction.
Grapefruit juice inhibits intestinal CYP3A4.
Chronic alcohol induces CYP2E1.
Acute alcohol may inhibit metabolism.
Prodrugs behave differently from active drugs.
Practical study-tip checklist
Before moving on from this topic, ensure you can:
□ Explain induction versus inhibition without memorisation.
□ List at least six major enzyme inducers.
□ List at least six major enzyme inhibitors.
□ Predict the effect on warfarin INR.
□ Predict interactions with oral contraceptives.
□ Explain what happens to prodrugs.
□ Recognise CYP450-based clinical scenarios.
□ Recall the difference in onset between induction and inhibition.
□ Identify which interactions increase toxicity.
□ Practise scenario-based MCQs rather than simple recall.
For further consolidation, combine this topic with the MRCP lectures and regular question practice in the Free MRCP MCQs.
Practical examples / mini-cases
Mini Case
A 62-year-old man with atrial fibrillation is stable on warfarin (INR 2.5). He develops pulmonary tuberculosis and starts rifampicin. Two weeks later, his INR is 1.3.
What best explains this finding?
A. Increased vitamin K absorption
B. Reduced warfarin absorption
C. Hepatic enzyme induction
D. Renal clearance of warfarin
E. Increased albumin binding
Answer: C. Hepatic enzyme induction
Explanation
Rifampicin strongly induces CYP450 enzymes, increasing warfarin metabolism. Plasma concentrations fall, producing a lower INR and increasing thromboembolic risk. This interaction is among the commonest pharmacology questions in MRCP Part 1.
Common pitfalls (5 bullets)
Confusing enzyme induction with enzyme inhibition.
Forgetting that induction develops over several days rather than immediately.
Assuming every drug interaction causes toxicity; induction often causes treatment failure instead.
Forgetting that prodrugs may become less effective with enzyme inhibition.
Memorising drug lists without understanding the underlying mechanism.
FAQs
Which enzyme inducers are most important for MRCP Part 1?
Focus on rifampicin, carbamazepine, phenytoin, phenobarbital, primidone and St John's Wort. These account for most examination questions.
Which enzyme inhibitors should I remember?
The highest-yield inhibitors are macrolides, azole antifungals, amiodarone, cimetidine, sodium valproate and grapefruit juice.
Why is warfarin commonly tested?
Warfarin has a narrow therapeutic index and numerous CYP450 interactions. Understanding induction and inhibition allows candidates to predict changes in INR.
Does enzyme induction always reduce drug efficacy?
No. It usually reduces concentrations of active drugs, but some prodrugs require metabolism for activation, making the clinical effect more complex.
How should I revise this topic effectively?
Start by understanding the mechanism, then memorise the major drug groups and practise clinical scenarios. Cross-reference your revision with the MRCP Part 1 overview, complete topic-based questions in the QBank, and read related articles such as Drug Metabolism and Pharmacokinetics for MRCP Part 1 and the MRCP Part 1 Study Plan to reinforce concepts.
Ready to start?
Mastering enzyme inducers and inhibitors can improve your performance across pharmacology, clinical medicine and therapeutics questions. Continue your preparation with the MRCP Part 1 overview, reinforce concepts using the Free MRCP MCQs, and consolidate difficult topics through our structured MRCP lectures.
Sources
MRCP(UK). Syllabus for the Membership of the Royal Colleges of Physicians examinations. https://www.mrcpuk.org/
British National Formulary (BNF). Drug interactions. https://bnf.nice.org.uk/
National Institute for Health and Care Excellence (NICE). Medicines guidance. https://www.nice.org.uk/
Katzung BG. Basic and Clinical Pharmacology. McGraw Hill.
Rang HP, Ritter JM, Flower RJ, Henderson G. Rang & Dale's Pharmacology.
Comments